Up to 4% cashback + 6% yieldGet Plasma One

ASML Holding N.V. (ASML) vs Johnson & Johnson (JNJ)

See how ASML Holding N.V. and Johnson & Johnson differ across market data and performance, so you can decide which asset best fits your strategy.

$1,676.69
NasdaqGS
View Full Page
$257.78
NYSE
Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.
View Full Page

Key Metrics Comparison

ASML Holding N.V.ASML
Market Cap
$646.226B
Price
$1,676.69
24h Change
+2.81%
24h Volume
$1.24M
Employees
44,681
Shares Outstanding
N/A
Johnson & JohnsonJNJ
Market Cap
$621.224B
Price
$257.78
24h Change
-0.61%
24h Volume
$6.19M
Employees
138,200
Shares Outstanding
2,407,216,971

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ASML
51.0%
JNJ
49.0%

Volume Share

Share of combined 24h volume

Volume Share
ASML
16.7%
JNJ
83.3%

24h Performance

Price change over last 24 hours

24h Performance
ASML
2.81%
JNJ
-0.61%
Price Comparison
ASML Holding N.V.
Johnson & Johnson